Arkolith/Insider Trading/XENT/Form 4

Kline Teresa L.

DirectorIntersect ENT, Inc. (XENT) · full profile →Form 4 · filed May 16, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
2 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2022Tender(U)3K$28.25$92K0
May 13, 2022Tender(U)9K$28.25$250K3K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 13, 2022Tender(U)6K$28.25$162K0
May 13, 2022Tender(U)3K$28.25$96K0
May 13, 2022Tender(U)5K$28.25$146K0
May 13, 2022Tender(U)3K$28.25$95K0
May 13, 2022Tender(U)3K$28.25$79K0
May 13, 2022Tender(U)14K$28.25$389K0
May 13, 2022Tender(U)10K$28.25$273K0
May 13, 2022Tender(U)3K$28.25$98K0
May 13, 2022Tender(U)3K$28.25$91K0

Transaction Codes

U
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-22-004070) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML